Sophia GENETICS SA current report, Q3 FY2021

SOPHiA GENETICS SA — Form 6-K Summary

Business Context and Reporting Period

SOPHiA GENETICS SA filed a Form 6-K as a foreign private issuer for the month of August 2021. The filing was submitted on August 24, 2021, under Commission File Number 001-40627. The company’s principal executive office is in Saint-Sulpice, Switzerland, and it files annual reports on Form 20-F.

Financial and Operating Metrics

The provided filing text is a cover page and does not include revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide information regarding changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing identifies an attached Exhibit 99.1 described as a press release dated August 24, 2021, but the press release content is not included in the provided text. Accordingly, guidance, outlook, management commentary, risks, contingencies, and unusual items cannot be assessed from this filing text.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the August 24, 2021 press release.
  • Verify whether the press release contains financial results, operating metrics, guidance, or material corporate developments.
  • Review the company’s applicable Form 20-F and subsequent filings for complete financial and risk disclosures.